Establishment of Murine Hybridoma Cells Producing Antibodies against Spike Protein of SARS-CoV-2.

导出 OA

翻译打印收藏纠错

作者： Nadezhda V,Antipova ^[1] ; Tatyana D,Larionova ^[2] ; Andrei E,Siniavin ^[3] ; Maria A,Nikiforova ^[4] ; Vladimir A,Gushchin ^[4] ; Igor I,Babichenko ^[5] ; Alexey V,Volkov ^[6] ; Michail I,Shakhparonov ^[2] ; Marat S,Pavlyukov ^[2]

作者单位： Department of Functioning of Living Systems, Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, 117997 Moscow, Russia.;Institute of Medicine, Peoples' Friendship University of Russia (RUDN University), 17198 Moscow, Russia.;Faculty of Biology and Biotechnology, National Research University Higher School of Economics, 101000 Moscow, Russia. ^[1] Department of Functioning of Living Systems, Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, 117997 Moscow, Russia. ^[2] Department of Functioning of Living Systems, Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, 117997 Moscow, Russia.;N.F. Gamaleya National Research Center for Epidemiology and Microbiology, Ministry of Health of the Russian Federation, 123098 Moscow, Russia. ^[3] N.F. Gamaleya National Research Center for Epidemiology and Microbiology, Ministry of Health of the Russian Federation, 123098 Moscow, Russia. ^[4] Institute of Medicine, Peoples' Friendship University of Russia (RUDN University), 17198 Moscow, Russia. ^[5] E.O. Mukhin Municipal Clinical Hospital, 111399 Moscow, Russia. ^[6]

关键词 COVID19 SARS-CoV-2 Spike RBD hybridoma monoclonal antibodies